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Summary  Leprosy  is  a chronic  disease  caused  by  Mycobacterium  leprae.  Although
the  occurrence  of  leprosy  has  declined  in  Saudi  Arabia,  it  has  not  yet  been  eradi-
cated.  To  our  knowledge,  this  descriptive  retrospective  study  is  the  ﬁrst  to  assess
the  clinical  presentation  of  leprosy  at  the  time  of  diagnosis  in  Saudi  Arabia.  All  study
subjects  were  leprosy  patients  admitted  to  Ibn  Sina  hospital,  the  only  referral  hos-
pital  for  leprosy  in  Saudi  Arabia,  between  January  2000  and  May  2012.  A  total  of  164
subjects,  the  majority  of  whom  (65%)  were  between  21  and  50  years  of  age,  were
included,  and  the  male-to-female  ratio  was  2.8:1.  Of  these  164  patients,  63%  were
Saudis,  and  77%  of  all  admitted  patients  were  from  the  western  region.  Lepromatous
leprosy  was  observed  most  frequently  (33%),  and  31%  of  cases  had  a  positive  history
of  close  contact  with  leprosy.  At  the  time  of  diagnosis,  84%  of  all  subjects  presented
with  skin  manifestation.  The  prevalence  of  neurological  deﬁcit  at  the  time  of  diag-
nosis  was  87%.  Erythema  nodosum  leprosum  (E.N.L.)  developed  in  only  10%  of  all
subjects.  Further  studies  are  needed  to  determine  the  clinical  characteristics  per-
taining  to  each  type  of  leprosy  in  the  region,  and  training  courses  in  caring  for  and
diagnosing  patients  with  le
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odds ratio  and  a  95%  conﬁdence  interval.  A  P  value612  
Introduction
Leprosy  is  a  chronic  disease  caused  by  Mycobac-
terium leprae  [1].  M.  leprae  is  similar  to
Mycobacterium  tuberculosis,  although  it  is  resistant
to culture  [1].  It  is  an  intracellular  microbe  that
prefers  to  infect  cooler  areas  of  the  human  body,
including the  skin  and  nerves  [2]. Dermatological
lesions and  peripheral  neuropathy  are  the  cardi-
nal clinical  features  of  leprosy  [1]. Most  cases  of
leprosy  have  been  reported  in  developing  countries
[1].  Leprosy  is a  curable  disease  if  detected  in  early
stages, and  early  detection  is  critical  for  the  pre-
vention  of  disabilities  [1].  In  the  United  States,
approximately 75%  of  new  cases  were  detected  in
immigrants  in  2010  [3]. Most  leprosy  patients  in  the
USA were  affected  by  lepromatous  leprosy  [3]. Of
diagnosed  leprosy  patients  in  Saudi  Arabia,  57%  are
immigrants,  and  leprosy  is  more  common  in  males
than females  at  a  ratio  of  3—1  [4].  Regarding  the
epidemiology in  Saudi  Arabia,  Assiri  et  al.  reported
the occurrence  of  242  new  leprosy  cases  over  a
10-year  period  spanning  2003—2012  [4]. The  risk
of leprosy  was  higher  in  older  individuals.  In  one
study, the  risk  of  contracting  the  disease  was  found
to increase  between  the  ages  of  5  and  15  years
and increased  again  after  the  age  of  30  [5].  The
disease  is  transmitted  from  one  person  to  another
through close  contact  [6],  which  in  the  case  of  lep-
rosy, may  mean  skin-to-skin  contact  or  exposure
to a  patient’s  oral  droplets  [7]. Some  studies  have
suggested  that  patients  with  a  history  of  contact
with multibacillary  leprosy  have  a  higher  risk  than
patients  in  contact  with  paucibacillary  leprosy  [6].
The disease  is  thought  to  be  transmitted  through
nasal discharge,  but  the  exact  mechanism  of  trans-
mission is  not  fully  understood  [8].
According  to  the  Ridley  and  Jopling  classiﬁcation
system, there  are  ﬁve  types  of  leprosy:  leproma-
tous (LL),  tuberculoid  (TT),  borderline  borderline
(BB), borderline  lepromatous  (BL)  and  borderline
tuberculoid (BT)  [9]. Ridley  and  Jopling  have  also
used the  term  indeterminate  leprosy  (IL)  [10]  when
a biopsy  sample  shows  evidence  of  leprosy  with-
out a  clear  clinical  manifestation  [10].  Patients
with evidence  of  neurological  deﬁcits  or  damage
without any  skin  manifestations  are  considered  to
have pure  neural  leprosy  [11]. Another  classiﬁca-
tion system  for  leprosy  was  developed  by  the  World
Health  Organization  (WHO).  The  WHO  divides  lep-
rosy into  two  types:  paucibacillary  (includes  TT,  BT
and IL)  and  multibacillary  (includes  LL,  BL  and  BB)
[12].  There  are  two  types  of  systemic  reactions  to
leprosy. Type  1  reactions  (i.e.,  reversed  reactions)
occur in  patients  with  borderline  leprosy  (i.e.,
borderline  borderline,  borderline  lepromatous  and
<
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orderline  tuberculoid),  whereas  type  2  reactions
i.e., erythema  nodosum  leprosum  or ENL)  occur
n patients  with  lepromatous  and  borderline  lepro-
atous  leprosy  [2]. ENL  presents  with  red  painful
odules  on  the  skin,  which  mostly  develop  later
n the  course  of  the  disease  [13].  The  manage-
ent of  ENL  compromises  prolonged  courses  of
rednisolone  [13]. If  the  disease  is  severe,  then
halidomide  may  be  used  [14].  The  aim  of  this
tudy  is  to  determine  the  demographics  of  patients
dmitted with  a  diagnosis  of  leprosy  and  to  assess
nd compare  neurological  deﬁcit  (e.g.,  sensory
r motor  loss,  nerve  enlargement  or  anesthetic
esion,), skin  manifestation  (e.g.,  hypopigmented
esions, plaque  or  macule)  and  erythema  nodosum
eprosum in  various  leprosy  types  in  Saudi  Arabia.
ecause  of  the  need  for  clinical  indicators  to  aid  pri-
ary healthcare  physicians  in  the  early  detection
f the  disease,  we  focused  our  efforts  on  quantify-
ng the  types  and  characteristics  of  leprosy  found
n Saudi  Arabia.  To  our  knowledge,  this  is the  ﬁrst
tudy to  assess  the  clinical  presentation  of  leprosy
t the  time  of  diagnosis  in  Saudi  Arabia.
ethodology
his  is  a  descriptive  retrospective  study.  The  sub-
ects of  this  study  were  all  patients  diagnosed  with
eprosy at  Ibn  Sina  Hospital  between  January  2000
nd May  2012.  The  study  was  conducted  in  Ibn  Sina
ospital, which  is a leprosy  referral  hospital  in  the
akkah  region.  In  total,  164  subjects  were  enrolled.
welve  subjects  were  excluded  from  our  study  due
o insufﬁcient  ﬁle  information.
Patient  information  and  data,  including  age,
ex, nationality,  area  of  residence,  year  of  reg-
stry, type  of  the  disease  and  signs  and  symptoms
t the  time  of  diagnosis,  were  collected  from
he patients’  ﬁles.  The  data  were  categorized
ccording  to  the  Ridley  and  Jopling  classiﬁcation
9]. The  diagnosis  of  leprosy  was  based  on  clinical
anifestations  in  addition  to  a skin  smear,  which
as obtained  for  all  patients  and  examined  in  a
aboratory  to  determine  the  type  of  leprosy.  The
ata were  transferred  to  coding  sheets  and  were
ntered into  an  Excel  ﬁle.  The  data  were  analyzed
sing SPSS  version  16.  Qualitative  variables  are
ategorized  and  presented  as  frequencies  and
ercentages.  Quantitative  variables  are  presented
s the  mean  and  standard  deviation.  Categorical
ariables were  compared  using  the  chi-square  test,0.05 was  considered  signiﬁcant.  Openepi,  which
s a  free  web-based  statistical  program,  was  used
o calculate  the  P  value,  odds  ratio  and  conﬁdence
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nterval  [15]  in  conjunction  with  SPSS  version  16.
pproval  for  the  study  was  obtained  from  the
irector of  health  affairs  in  Makkah.  All  subjects
ere anonymized  during  data  entry.
esults
n  this  study,  we  considered  patients  diagnosed
ith leprosy  at  Ibn  Sina  Hospital  from  January
000 to  May  2012.  We  enrolled  a  total  of  164
ubjects after  excluding  patients  with  incomplete
les. Of  these  subjects,  the  majority  of  patients
65%) were  between  21  and  50  years  old.  Subjects
ver 50  years  old  comprised  31%  of  the  cohort,
nd only  seven  (4%)  of  the  subjects  were  under
0 years  old.  The  mean  age  of  the  study  group
as 43.24  + 17.1,  and  the  male-to-female  ratio
as 2.8:1  [121  subjects  (74%)  were  male  and  43
26%) were  female].  Of  the  164  reported  patients,
03 (63%)  were  Saudis.  The  majority  of  patients
 127  (77%)  —  were  from  the  western  region.  The
outhern region  had  the  second  largest  number  of
ases at  31  (19%).  The  number  of  patients  reported
rom northern  region  was  three  (2%),  while  two
ere reported  from  the  central  region  (1%)  and
ne (1%)  was  from  the  eastern  region.  These  data
ndicate  that  the  disease  may  be  concentrated  in
he western  region  of  Saudi  Arabia  (Table  1).
Using Ridley  and  Jopling’s  classiﬁcation  system,
epromatous leprosy  affected  the  highest  num-
er of  infected  subjects  [54  (33%)].  The  number
f subjects  affected  by  the  other  types  were  as
ollows:  borderline  tuberculoid  leprosy,  42  (26%);
uberculoid  leprosy,  26  (16%);  borderline  borderline
eprosy,  22  (13%);  borderline  lepromatous  leprosy,
3 (8%);  pure  neural  leprosy,  ﬁve  (3%);  and  indeter-
inate  leprosy,  two  (1%)  (Table  2).
There  was  a  positive  history  of  close  contact,
kin-to-skin contact,  exposure  to  a  patient’s  oral
roplets  or  prior  leprosy  in  31%  of  cases.  Specif-
cally, three  (60%)  of  the  subjects  exhibited  pure
eural leprosy,  11  (42%)  tuberculoid  leprosy,  14
33%) borderline  tuberculoid  leprosy,  four  (31%)
orderline  lepromatous  leprosy,  16  (30%)  leproma-
ous leprosy  and  three  (14%)  borderline  borderline
eprosy. In contrast,  none  of  the  patients  with  inde-
erminate  leprosy  reported  close  contact  history.  In
ccordance with  WHO  classiﬁcation,  we  excluded
ve subjects  who  had  been  diagnosed  with  pure
eural leprosy,  which  is not  included  in  the  WHO
ystem. This  criterion  resulted  in  the  inclusion  of
59 subjects  rather  than  164  in  this  comparison.
f patients  with  Multibacillary  leprosy,  23  (26%)
eported  a  close  contact  history,  while  25  (36%)
atients with  Paucibacillary  leprosy  reported  close
ontact  (Table  3).
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Regarding  clinical  presentation  at  the  time  of
iagnosis,  84%  of  our  subjects  presented  with  skin
anifestation.  Borderline  borderline  leprosy  was
ost frequently  associated  with  skin  manifestation,
ith 96%  of  patients  presenting  with  this  feature.
orderline lepromatous  followed  with  92%,  lepro-
atous  with  91%,  borderline  tuberculoid  with  86%
nd tuberculoid  with  65%,  with  clinically  signiﬁcant
ifferences (P  <  0.05).  Finally,  pure  neural  leprosy
ever presented  with  skin  manifestation  (P  < 0.05).
lthough  pure  neural  leprosy  does  not  present  with
kin manifestation  at  the  time  of  diagnosis,  such
ymptoms  may  develop  over  time,  as  leprosy  is
ighly unpredictable  [16]. It is  worth  mentioning
hat our  indeterminate  subjects  (100%)  presented
ith skin  manifestation  at  the  time  of  diagnosis
Table  4).
In total,  87%  of  subjects  presented  with  a  neuro-
ogical  deﬁcit  at  the  time  of  diagnosis  All  subjects
ho were  diagnosed  with  tuberculoid  or  pure  neural
eprosy  had  neurological  symptoms  (100%).  Border-
ine lepromatous  patients  followed  at  92%,  then
orderline  borderline  at  91%.  Borderline  tubercu-
oid and  lepromatous  patients  were  affected  in
6% and  80%  of  cases,  respectively.  Lepromatous
atients exhibited  a clinically  signiﬁcant  difference
t P  <  0.05.  Finally,  one  subject  with  indeterminate
eprosy (50%)  had  neurological  deﬁcits  (Table  5).
Table  6 shows  that  ENL  developed  in  only  10%
f all  subjects.  It  was  signiﬁcantly  associated  with
orderline  lepromatous  leprosy,  as  46%  of  these
atients  developed  ENL  (P  <  0.001).  There  was  also
 signiﬁcant  association  between  ENL  and  lepro-
atous leprosy,  as  19%  of patients  developed  the
omplication  (P  <  0.05).  One  subject  diagnosed  with
orderline  borderline  leprosy  (5%)  developed  ENL,
hile the  rest  of  the  types  did  not  exhibit  any
nvolvement of  ENL.
iscussion
eprosy  is  one  of  the  oldest  diseases  known  to
ankind [17].  Its  prevalence  has  been  in  decline
orldwide at  least  since  the  ﬁrst  Leprosy  Expert
ommittee meeting  of  the  WHO  in  1956  [18]. Nev-
rtheless,  there  remain  endemic  areas  affected  by
eprosy, such  as  India  and  Indonesia  [19].  The  dis-
ase is  known  to  exist  in  Saudi  Arabia  [20], and
lthough  the  exact  number  of  infected  patients
s not  precisely  known,  it  does  not  pose  a public
ealth problem.  Assiri  et  al.  reported  a  total  of
42 infected  residents  in  Saudi  Arabia  nationwide
ver a  10-year  period  (2003—2012)  [4]. In  our  study,
e focused  on  leprosy  patients  admitted  to  the
bn Sina  Hospital,  which  is  the  only  referral  center
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for  leprosy  in  the  country.  A  total  of  164  patients
were treated  over  a  12-year  period.  Although  more
patients  were  admitted  to  Ibn  Sina  Hospital  dur-
ing this  time,  12  subjects  were  excluded  from
our study  due  to  insufﬁcient  ﬁle  information.  It  is
believed that  the  number  of  leprosy  patients  in
Saudi Arabia  is  greater  than  is  reported  because
leprosy is  stigmatized  in  society;  we  may  not  be
able to  precisely  account  for  all  leprosy  patients
in Saudi  Arabia  because  many  travel  abroad  for
treatment  [21].  The  total  number  of  Saudis  world-
wide  with  leprosy  has  not  yet  been  described  in
the literature.  New  cases  must  be  self-reported
by patients,  as  there  are  no  surveillance  studies
[21].  The  non-speciﬁc  clinical  presentation,  the
lack of  involvement  of  structures  other  than  skin
and peripheral  nerves,  the  long  incubation  period
of the  disease,  and  its  atypical  clinical  presenta-
tions all  make  the  diagnosis  of  leprosy  challenging,
especially in  non-endemic  countries  [22].  Neverthe-
less, there  has  been  a  decline  in  the  incidence  of
leprosy  in  Saudi  Arabia  [4].
Atypical forms  of  the  disease  have  been  reported
in the  literature,  and  the  emergence  of  newer  forms
can lead  to  a  delay  in  diagnosis  [23]:  an  estimated
82% of  leprosy  cases  are  misdiagnosed  in  the  UK
[22].  Thus,  there  is  a  need  to  identify  clinical  indi-
cators to  aid  in  the  early  detection  of  the  disease.
To this  end,  we  focused  our  efforts  on  quantifying
the types  of  leprosy  found  in  Saudi  Arabia  and  their
characteristics  according  to  the  Ridley  and  Jopling
classiﬁcation  rather  than  the  WHO  classiﬁcation,  as
well as  adding  pure  neural  leprosy  as  a  separate
class. The  majority  of  our  subjects  were  afﬂicted
with lepromatous  leprosy  (33%).  To  compare  our
results with  those  of  Assiri  et  al.,  we  utilized  the
WHO classiﬁcation  system.  Assiri  et  al.  reported
that the  majority  of  cases  were  PB  (50.8%)  [4]. In
our study,  PB  accounted  for  43%  of  leprosy  patients
in Ibn  Sina  Hospital,  most  of  which  were  borderline
tuberculoid (26%),  while  54%  had  MB  and  only  3%
had pure  neural  leprosy.  In  our  study,  MB  was  the
most common  type  of  leprosy.
Furthermore,  a  huge  number  of  non-Saudis
— particularly  from  India  and  Indonesia,  known
endemic areas  for  leprosy  —  come  to  Saudi  Arabia
for religious  reasons  or  for  work  [19]  and  may  have
inactive  or  undiagnosed  leprosy.  This  is  in  line  with
the ﬁndings  of  Al-Mutairi  et  al.,  who  reported  that
73.9% of  leprosy  cases  in  Kuwait  originated  in  India
and its  neighboring  countries  [24]. Our  ﬁndings  sug-
gest that  only  37%  of  patients  were  non-Saudis.
This may  be  because  foreigners  diagnosed  with  lep-
rosy are  treated  for  one  month  and  then  are  sent
back to  their  home  country  [4]. To  compare  immi-
grants  in  Saudi  Arabia,  Assiri  et  al.  reported  that
C
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7.4%  of  cases  were  non-Saudis  [4]. As  expected,
ales are  affected  more  frequently  with  the  dis-
ase than  females,  with  a  male-to-female  ratio  of
.8:1. This  is  consistent  with  studies  conducted  in
audi Arabia  and  elsewhere  [4,21], which  indicate
atios ranging  from  3.4:1  to  3.83:1  [4,20].  In  addi-
ion, the  geographical  distribution  of  the  disease
onﬁrmed  the  results  of  previous  studies  conducted
n Saudi  Arabia.  Al  Aboud  et  al.  reported  that  45%  of
eprosy patients  came  from  the  western  region  of
audi Arabia  [21]. Makkah  had  the  highest  number
f cases,  representing  42%  of  all  reported  cases  in
ssiri et  al.’s  study  [4]. Our  study  indicated  that  77%
f subjects  were  from  the  western  region.  We  found
hat the  second  highest  region  of  leprosy  cases  was
he Southern  region,  with  19%.  However,  accord-
ng to  Assiri  et  al.,  the  second  highest  incidence  of
eprosy was  the  eastern  region,  with  20%  of  cases
4]. Only  1%  of  our  subjects  were  from  the  east-
rn region.  This  could  be  due  to  the  geographical
ocation of  Ibn  Sina  Hospital  in  the  western  region.
urthermore,  we  found  that  a  history  of  close  con-
act was  prominent  in  patients  with  PB  leprosy,
hich is  contrary  to  other  reports  in  the  literature
6]. This  may  be  due  to  the  subjective  approach
f the  diagnosing  physician  when  taking  a history
t the  time  of  diagnosis.  Rodrigues  et  al.  stated
hat  the  risk  of  infection  is  almost  doubled  for  MB
ompared  to  PB  [25]. Interestingly,  there  is  no  skin
anifestation  for  patients  with  pure  neural  leprosy
t the  time  of diagnosis,  although  it  may  develop  in
ater stages  [26]. This  illustrates  the  unpredictable
resentation  of  leprosy  [16].
Tuberculoid leprosy  is  known  to  present  with
 neurological  deﬁcit  at  diagnosis  [27,28].  This
as observed  in  our  subjects;  all  patients  with
uberculoid  leprosy  (100%)  exhibited  some  form
f neurological  deﬁcit.  In  cases  of  lepromatous
eprosy, neurological  deﬁcits  are  less  likely  to  be
resent  at  the  time  of  diagnosis,  but  can  occur
n later  stages  [26]. The  prevalence  of  neurologi-
al deﬁcit  was  80%  in  our  subjects  diagnosed  with
epromatous  leprosy.  ENL  is  a  rare  complication  of
eprosy in  general,  but  as  expected,  was  a common
omplication in  lepromatous  leprosy  and  borderline
epromatous leprosy  [2,26,27,29]. Out  of  all  164
ubjects,  only  17  (10%)  developed  ENL,  10  of  which
ere affected  by  lepromatous  leprosy  and  six  of
hich had  borderline  lepromatous  leprosy.onclusion/Recommendation
lthough  leprosy  is  not  a major  public  health  prob-
em in  Saudi  Arabia  and  the  number  of reported
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Mhe  demographic  and  clinical  characteristics  of  lep
ases  has  decreased  over  the  past  several  years,
t has  not  been  eradicated.  Leprosy  cases  are  con-
entrated  in  the  western  and  southern  regions.  Our
tudy describes  the  demographics  and  the  pattern
f clinical  presentation  of  different  types  of  lep-
osy. Further  studies  are  needed  to  investigate  the
linic characteristics  pertaining  to  each  type  of
eprosy in  the  region  because  it  is important  to
iagnose  the  disease  in  its  early  stages  to  prevent
omplications. Training  courses  should  be  organized
or  health  workers  involved  in  caring  for  patients
ith leprosy,  including  dermatologists,  microbiolo-
ists and  physiotherapists.  Courses  on  the  diagnosis
f leprosy  should  be  organized  for  primary  health-
are physicians.unding
o  funding  sources. A
Table  1  Demographic  data  of  patients  with  leprosy  in  Saud
Demographic  items  
Age  mean  43.24  ±  17.1
Age  range  (years)  Frequency  (n)  
<20  7  
21—50  106  
>50  51  
Sex  Male  121  
Female  43  
Nationality  Saudi  103  
Non-Saudi  61  
Region  Northern  3  
Southern  31  
Western  127  
Eastern  1  
Central  2  
Table  2  Classiﬁcation  of  leprosy  in  patients  reported  in  Sa
Type  of  disease  Frequency  (n)  
Lepromatous  54  
Tuberculoid  26  
Borderline  borderline  22  
Borderline  tuberculoid  42  
Borderline  lepromatous  13  
Pure  neural  5  
Indeterminate  2  
Total  164   in  Saudi  Arabia  615
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164 100
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Table  3  The  association  between  the  type  of  leprosy  and  the  close  contact  history  with  the  disease  among  Saudi
patients  (2000—2012).
Type  of  leprosy  (Ridley  and  Jopling  classiﬁcation)  Close  contact  (n  =  164)  Total  (%)  P-value
Yes  (n  =  51)  No  (n  =  113)
Lepromatous  16  (30) 38  (70) 54  (33) 0.77
Tuberculoid 11  (42) 15  (58) 26  (16) 0.17
Borderline  borderline 3  (14) 19  (86) 22  (13) 0.057
Borderline  tuberculoid 14  (33) 28  (67) 42  (26) 0.71
Borderline  lepromatous 4  (31) 9  (69) 13  (8) 0.97
Pure neural 3  (60) 2  (40) 5  (3) 0.15
indeterminate  0  (0) 2  (100) 2  (1) >0.99*
Type  of  leprosy  (WHO  classiﬁcation) Close  contact  (n  =  159) Total  (%) P-value
Yes  (n  =  48)  No  (n  =  111)
Multibacillary  (MB)  23  (26)  66  (74)  89  (54)  0.18
Paucibacillary  (PB)  25  (36)  45  (64)  70  (43)  0.18
* Fisher exact test.
Table  4  The  association  between  the  type  of  leprosy  and  skin  manifestation  in  Saudi  Arabia  (2000—2012).
Type  of  leprosy  Skin  manifestation  (n  =  164)  Total  (%)  P-value  Odds  ratio  95%  C.I.
Yes  (n  =  137)  No  (n  =  27)
Lepromatous  49  (91)  5  (9)  54  (33)  0.08  2.45  0.87,  6.87
Tuberculoid 17  (65)  9  (35)  26  (16)  <0.05  0.28  0.11,  0.73
Borderline borderline 21  (96)  1  (4)  22  (13)  0.10  4.70  0.60,  36.60
Borderline tuberculoid  36  (86)  6  (14)  42  (26)  0.65  1.24  0.47,  3.33
Borderline lepromatous  12  (92)  1  (8)  13  (8)  0.37  2.50  0.31,  20.04
Pure neural  0  (0)  5  (100)  5  (3)  <0.05* 0.038  0.0007,  0.38
Indeterminate  2  (100)  0  (0)  2  (1)  >0.9* 0.62  0.025,  47.93
* Fisher exact test.
Table  5  The  association  between  the  type  of  leprosy  and  neurological  deﬁcits  in  Saudi  Arabia  (2000—2012).
Type  of  leprosy  Neurological  deﬁcits  (n  =  164)  Total  (%)  P-value  Odds  ratio  95%  C.I.
Yes  (n  =  143)  No  (n  =  21)
Lepromatous  43  (80)  11  (20)  54  (33)  <0.05  0.39  0.15,  0.99
Tuberculoid 26  (100)  0  (0)  26  (16)  0.21* 4.31  0.62,  186.9
Borderline borderline  20  (91)  2  (9)  22  (13)  0.57  1.54  0.33,  7.14
Borderline tuberculoid  36  (86)  6  (14)  42  (26)  0.73  0.84  0.30,  2.33
Borderline lepromatous  12  (92)  1  (8)  13  (8)  0.56  1.83  0.22,  14.86
Pure neural  5  (100)  0  (0)  5  (3)  >0.99* 1.15  0.095,  73.4
Indeterminate  1  (50)  1  (50)  2  (1)  0.11  0.14  0.008,  2.34
* Fisher exact test.
Table  6  The  association  between  the  type  of  leprosy  and  erythema  nodosum  leprosum  in  Saudi  Arabia
(2000—2012).
Type  of  leprosy  E.N.L.  (n  =  164)  Total  (%)  P-value  Odds  ratio  95%  C.I.
Yes  (n  =  17)  No  (n  =  147)
Lepromatous  10  (19)  44  (81)  54  (33)  <0.05  3.34  1.20,  9.35
Tuberculoid 0  (0)  26  (100)  26  (16)  0.40* 0.30  0.007,  2.11
Borderline borderline  1  (5)  21  (95)  22  (13)  0.34  0.37  0.047,  3.002
Borderline tuberculoid  0  (0)  42  (100)  42  (26)  0.06* 0.16  0.003,  1.09
Borderline lepromatous  6  (46)  7  (54)  13  (8)  <0.001  11  3.12,  38.12
Pure neural  0  (0)  5  (100)  5  (3)  0.9* 1.98  0.039,  20.24
Indeterminate  0  (0)  2  (100)  2  (1)  0.48* 5.90  0.087,  142.7
* Fisher exact test.
T rosy
R
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[he  demographic  and  clinical  characteristics  of  lep
eferences
[1] World Health Organization. Leprosy [Internet]; 2015
[cited 16 November 2015]. Available from: http://www.
who.int/mediacentre/factsheets/fs101/en/.
[2] Scollard D, Adams L, Gillis T, Krahenbuhl J, Truman R,
Williams D. The continuing challenges of leprosy. Clin Micro-
biol Rev 2006;19(2):338—81.
[3] Hrsa.gov. Hansen’s Disease Data & Statistics [Internet];
2015 [cited 24 November 2015]. Available from: http://
www.hrsa.gov/hansensdisease/dataandstatistics.html.
[4] Assiri A, Yezli S, Tayeb T, Almasri M, Bamgboye A, Mem-
ish Z. Eradicating leprosy in Saudi Arabia: outcome of a
ten-year surveillance (2003—2012). Travel Med Infect Dis
2014;12(6):771—7.
[5] Moet FJ, Pahan D, Schuring RP, Oskam L, Richardus
JH. Physical distance, genetic relationship, age, and
leprosy classiﬁcation are independent risk factors for lep-
rosy in contacts of patients with leprosy. J Infect Dis
2006;193(3):346—53.
[6] van Beers SM, Hatta M, Klatser PR. Patient contact is the
major determinant in incident leprosy: implications for
future control. Int J Lepr Other Mycobact Dis 1999.
[7] Who.int. WHO | Transmission of leprosy [Internet]; 2015
[cited 16 November 2015]. Available from: http://www.
who.int/lep/transmission/en/index4.html.
[8] Abraham S, Mozhi NM, Joseph GA, Kurian N, Rao PS, Job CK.
Epidemiological signiﬁcance of ﬁrst skin lesion in leprosy.
Int J Lepr Other Mycobact Dis 1998;66(2):131—9.
[9] Ridley DS, Jopling WH. Classiﬁcation of leprosy according to
immunity. A ﬁve-group system. Int J Lepr Other Mycobact
Dis 1966;34(3):255—73.
10] Bestpractice.bmj.com. BMJ Best Practice [Internet];
2015 [cited 16 November 2015]. Available from: http://
bestpractice.bmj.com/best-practice/monograph/923/
basics/classiﬁcation.html.
11] Jardim M, Antunes S, Santos A, Nascimento O, Nery J, Sales
A, et al. Criteria for diagnosis of pure neural leprosy. J
Neurol 2003;250(7):806—9.
12] Pardillo F, Fajardo T, Abalos R, Scollard D, Gelber R. Methods
for the classiﬁcation of leprosy for treatment purposes. Clin
Infect Dis 2007;44(8):1096—9.
13] Saunderson P, Gebre S, Byass P. ENL reactions in
the multibacillary cases of the AMFES cohort in cen-
tral Ethiopia: incidence and risk factors. Lepr Rev
2000;71.(3).
14] Tadesse A, Abebe M, Bizuneh E, Mulugeta W,  Aseffa A, Shan-
non E. Effect of thalidomide on the expression of TNF-
m-RNA and synthesis of TNF- in cells from leprosy patients
[
Available  online  at  www
ScienceD in  Saudi  Arabia  617
with reversal reaction. Immunopharmacol Immunotoxicol
2006;28(3):431—41.
15] Openepi.com. OpenEpi Epidemiologic Statistics [Inter-
net]; 2015 [cited 24 November 2015]. Available from:
http://www.openepi.com.
16] Srinivasan H. Models for leprosy. An appraisal of graphic
representations of the spectrum concept as models and a
suggestion for a catastrophe theory model for leprosy. Int J
Lepr Other Mycobact Dis 1984;52(3):402—13.
17] Robbins G, Tripathy V, Misra V, Mohanty R, Shinde V, Gray K,
et al. Ancient skeletal evidence for leprosy in India (2000
B.C.). PLoS ONE 2009;4(5):e5669.
18] Reibel F, Cambau E, Aubry A. Update on the epidemiology,
diagnosis, and treatment of leprosy. Médecine et Maladies
Infectieuses 2015;45(9):383—93.
19] World Health Organization R. Leprosy: overcoming the
remaining challenges. World Health Organization [Inter-
net]; 2015 [cited 24 November 2015]. Available from:
http://apps.who.int/iris/handle/10665/164331.
20] Ibrahim MA, Kordy MN, Aiderous AH, Bahnassy A. Leprosy in
Saudi Arabia, 1986—89. Lepr Rev 1990;61(4):379—85.
21] Al Aboud F, Al Aboud K. Leprosy in Saudi Arabia. Lepr Rev
2007;78(4):405—8.
22] Lockwood DN, Reid AJ. The diagnosis of leprosy is delayed
in the United Kingdom. QJM 2001;94(4):207—12.
23] Kerkeni N, El Fékih N, Fazaa B, Zéglaoui F, Mnif E,
Kamoun M. A delayed diagnosis of lepromatous leprosy:
pitfalls and clues to early recognition. Int J Dermatol
2011;50(11):1383—6.
24] Al-Mutairi N, Al-Doukhi A, Ahmad MS, El-Khelwany M, Al-
Haddad A. Changing demography of leprosy: Kuwait needs
to be vigilant. Int J Infect Dis 2010;14(10):e876—80.
25] Rodrigues L, Lockwood D. Leprosy now: epidemiology,
progress, challenges, and research gaps. Lancet Infect Dis
2011;11(6):464—70.
26] Dwight P, Vijay P. Hansen disease (Mycobacterium leprae).
In: Kliegman RM, Stanton BF, Geme St. JW, et al., editors.
Nelson textbook of pediatrics. 19th ed. London: Sauders;
2011. p. 1010—4.
27] Joel D. Leprosy (Hansen’s disease). In: Goldman L, Andrew I,
editors. Goldman’s cecil medicine. 24th ed. London: Saun-
ders; 2011. p. 1950—4.
28] Hansen’s disease.William D, Timothy G, Dirk M, editors.
Andrews’ disease of the skin clinical dermatology. 11th ed.
London: Saunders; 2011. p. 334—44.
29] Cybele A, Joel D. Mycobacterium leprae. In: Mandell, Doug-
las, Bennett’s, editors. Principle and practice of infectious
disease. 7th ed. Philadelphia: Churchill Livinstone; 2010. p.
3165—76.
.sciencedirect.com
irect
